Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The brave new world of endometrial cancer : Future implications for adjuvant treatment decisions.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] - 1 Nov 2020

Marnitz S, Waltar T, Köhler C, Mustea A, Schömig-Markiefka B

Abstract excerpt

PURPOSE: For many decades, endometrial cancer (EC) has been considered as a homogenous tumor entity with good prognosis. The currently valid risk stratification considers clinical and pathological factors. Treatment recommendations differ considerably from country to country. MATERIALS AND METHODS: The Cancer Genome Atlas (TCGA) Research Network has shown that ECs should be reclassified into four novel molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Endometrioid
Share to Clinical Decision-Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogens

Share to Forecasting

Share to Genes, Neoplasm

Share to Neoplasms, Hormone-Dependent

Share to Progesterone

Share to Radiotherapy, Adjuvant

Source

Identifiers

PMID: 32430662
DOI: 10.1007/s00066-020-01632-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The brave new world of endometrial cancer : Future implications for adjuvant treatment decisions.PMID 32430662Read ↗

Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment ChangesSemantic proximity Read ↗

Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.Semantic proximity Read ↗

Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment.Semantic proximity Read ↗

Molecular Classification of Endometrial Carcinomas: Review and Recent UpdatesSemantic proximity Read ↗

A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?Semantic proximity Read ↗

New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere.Semantic proximity Read ↗

Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk FactorsSemantic proximity Read ↗

Molecular classification of endometrial carcinoma: a clinically oriented reviewSemantic proximity Read ↗

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read ↗

New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles.Semantic proximity Read ↗

Molecular classification of endometrial carcinoma, is it the new era of precision medicine?Semantic proximity Read ↗

Endometrial Cancer: Transitioning from Histology to Genomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.